Re-adapting T cells for cancer therapy: from mouse models to clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re-adapting T cells for cancer therapy: from mouse models to clinical trials

Published:2013-12-13 Issue:1 Volume:257 Page:145-164
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Stromnes Ingunn M.¹²,Schmitt Thomas M.¹,Chapuis Aude G.¹,Hingorani Sunil R.³⁴,Greenberg Philip D.¹²⁴

Affiliation:

1. Clinical Research Division; Program in Immunology; Fred Hutchinson Cancer Research Center; Seattle WA USA

2. Department of Immunology; University of Washington; Seattle WA USA

3. Clinical Research Division and Public Health Sciences Division; Fred Hutchinson Cancer Research Center; Seattle WA USA

4. Department of Medicine; Division of Medical Oncology; University of Washington School of Medicine; Seattle WA USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12141/fullpdf

Reference180 articles.

1. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat Immunol,2002

2. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression;DuPage;Cancer Cell,2011

3. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts;Weiden;N Engl J Med,1979

4. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors;Dighe;Immunity,1994

5. Neonatal thymectomy and non-viral mammary tumours in mice;Burstein;Nature,1971

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical immunology: Recent advances in tool development and applications;Cell Chemical Biology;2024-03

2. CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity;Neurology Neuroimmunology & Neuroinflammation;2023-03

3. Germline T cell receptor exchange results in physiological T cell development and function;Nature Communications;2023-02-01

4. Combination immunotherapy for pancreatic cancer: challenges and future considerations;Expert Review of Clinical Immunology;2022-09-11

5. Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?;Journal for ImmunoTherapy of Cancer;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3